2 31/03/2024 2024-03-31 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-04-01 Sage Accounts Production 23.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 10665596 2023-04-01 2024-03-31 10665596 2024-03-31 10665596 2023-03-31 10665596 2022-04-01 2023-03-31 10665596 2023-03-31 10665596 2022-03-31 10665596 bus:RegisteredOffice 2023-04-01 2024-03-31 10665596 bus:Director1 2023-04-01 2024-03-31 10665596 bus:Director2 2023-04-01 2024-03-31 10665596 core:WithinOneYear 2024-03-31 10665596 core:WithinOneYear 2023-03-31 10665596 bus:Director1 2023-03-31 10665596 bus:Director1 2024-03-31 10665596 bus:Director1 2022-03-31 10665596 bus:Director1 2023-03-31 10665596 bus:Director1 2022-04-01 2023-03-31 10665596 bus:Micro-entities 2023-04-01 2024-03-31 10665596 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 10665596 bus:FullAccounts 2023-04-01 2024-03-31 10665596 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 10665596 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31
Company registration number: 10665596
Wessex Pharma Consulting Ltd
Unaudited filleted financial statements
31 March 2024
Wessex Pharma Consulting Ltd
Contents
Directors and other information
Statement of financial position and notes to the financial statements
Wessex Pharma Consulting Ltd
Directors and other information
Directors Roger Carl McDonald
Susan Patricia McDonald
Company number 10665596
Registered office Sullivan Court, Wessex Way
Colden Common
Winchester
Hampshire
SO21 1WP
Wessex Pharma Consulting Ltd
Statement of financial position
31 March 2024
2024 2023
£ £ £ £
Current assets 503,874 520,769
Prepayments and accrued income 36,702 26,367
_______ _______
540,576 547,136
Creditors: amounts falling due within one year ( 45,932) ( 52,712)
_______ _______
Net current assets 494,644 494,424
_______ _______
Total assets less current liabilities 494,644 494,424
Accruals and deferred income ( 1,000) ( 1,000)
_______ _______
Net assets 493,644 493,424
_______ _______
Capital and reserves 493,644 493,424
_______ _______
Notes to the financial statements
Wessex Pharma Consulting Ltd
Year ended 31 March 2024
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 2 ).
2. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2024
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
Roger Carl McDonald ( 12,484) 219 ( 12,265)
_______ _______ _______
2023
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
Roger Carl McDonald ( 3,855) ( 8,629) ( 12,484)
_______ _______ _______
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 18 September 2024 , and are signed on behalf of the board by:
Roger Carl McDonald
Director
Company registration number: 10665596
The company is a private company limited by shares, registered in England.